Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey Gabelle

Showing results (121-130 of 171) with videos related to

Pageof 18
Sort By:
Journal of Neuroinflammation|July 31, 2024
Tracking neuroinflammatory biomarkers in Alzheimer's disease: a strategy for individualized therapeutic approaches?Simone Lista, Bruno P Imbimbo, Margherita Grasso, et al.
Alzheimer'S Research & Therapy|October 3, 2020
Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individualsSylvain Lehmann, Julien Dumurgier, Xavier Ayrignac, et al.
JAMA Neurology|September 18, 2013
SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosisIsabelle Le Ber, Agnès Camuzat, Rita Guerreiro, et al.
Plos One|February 20, 2014
Systemic delivery of siRNA down regulates brain prion protein and ameliorates neuropathology in prion disorderSylvain Lehmann, Aroa Relano-Gines, Sarah Resina, et al.
Journal of Neurology|October 29, 2013
Impact of cerebro-spinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric studyFrançois Mouton-Liger, David Wallon, Anne-Cécile Troussière, et al.
Journal of Alzheimer'S Disease : JAD|August 7, 2023
Different Trajectories of Apathy and Depression Among Subjective Cognitive Impairment Individuals with or without Conversion to Dementia: Results from the Memento Cohort in FranceAnamaria Bogdan, Roxane Fabre, Thomas Desmidt, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 11, 2020
Subjective cognitive and non-cognitive complaints and brain MRI biomarkers in the MEMENTO cohortVirginie Dauphinot, Vincent Bouteloup, Jean-François Mangin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 5, 2022
Associations among hypertension, dementia biomarkers, and cognition: The MEMENTO cohortJérémie Lespinasse, Geneviève Chêne, Jean-Francois Mangin, et al.
Clinical Chemistry|February 11, 2012
Cerebrospinal fluid collection tubes: a critical issue for Alzheimer disease diagnosisArmand Perret-Liaudet, Mathieu Pelpel, Yannick Tholance, et al.
Journal of Alzheimer'S Disease : JAD|April 13, 2012
Risk of Alzheimer's disease biological misdiagnosis linked to cerebrospinal collection tubesArmand Perret-Liaudet, Mathieu Pelpel, Yannick Tholance, et al.
Pageof 18

Showing results (121-130 of 171) with videos related to

Sort By:
Pageof 18
Journal of Neuroinflammation|July 31, 2024
Tracking neuroinflammatory biomarkers in Alzheimer's disease: a strategy for individualized therapeutic approaches?Simone Lista, Bruno P Imbimbo, Margherita Grasso, et al.
Alzheimer'S Research & Therapy|October 3, 2020
Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individualsSylvain Lehmann, Julien Dumurgier, Xavier Ayrignac, et al.
JAMA Neurology|September 18, 2013
SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosisIsabelle Le Ber, Agnès Camuzat, Rita Guerreiro, et al.
Plos One|February 20, 2014
Systemic delivery of siRNA down regulates brain prion protein and ameliorates neuropathology in prion disorderSylvain Lehmann, Aroa Relano-Gines, Sarah Resina, et al.
Journal of Neurology|October 29, 2013
Impact of cerebro-spinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric studyFrançois Mouton-Liger, David Wallon, Anne-Cécile Troussière, et al.
Journal of Alzheimer'S Disease : JAD|August 7, 2023
Different Trajectories of Apathy and Depression Among Subjective Cognitive Impairment Individuals with or without Conversion to Dementia: Results from the Memento Cohort in FranceAnamaria Bogdan, Roxane Fabre, Thomas Desmidt, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 11, 2020
Subjective cognitive and non-cognitive complaints and brain MRI biomarkers in the MEMENTO cohortVirginie Dauphinot, Vincent Bouteloup, Jean-François Mangin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 5, 2022
Associations among hypertension, dementia biomarkers, and cognition: The MEMENTO cohortJérémie Lespinasse, Geneviève Chêne, Jean-Francois Mangin, et al.
Clinical Chemistry|February 11, 2012
Cerebrospinal fluid collection tubes: a critical issue for Alzheimer disease diagnosisArmand Perret-Liaudet, Mathieu Pelpel, Yannick Tholance, et al.
Journal of Alzheimer'S Disease : JAD|April 13, 2012
Risk of Alzheimer's disease biological misdiagnosis linked to cerebrospinal collection tubesArmand Perret-Liaudet, Mathieu Pelpel, Yannick Tholance, et al.
Pageof 18